{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:04:06Z","timestamp":1778493846013,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K17496"],"award-info":[{"award-number":["JP19K17496"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K22877"],"award-info":[{"award-number":["JP20K22877"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17K09430"],"award-info":[{"award-number":["JP17K09430"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18H05039"],"award-info":[{"award-number":["JP18H05039"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","award":["2021Y010"],"award-info":[{"award-number":["2021Y010"]}],"id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","award":["2018G015"],"award-info":[{"award-number":["2018G015"]}],"id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["TKDS20190416055"],"award-info":[{"award-number":["TKDS20190416055"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ornithine transcarbamylase deficiency (OTCD) is most common among urea cycle disorders (UCDs), defined by defects in enzymes associated with ureagenesis. Corticosteroid administration to UCD patients, including OTCD patients, is suggested to be avoided, as it may induce life-threatening hyperammonemia. The mechanism has been considered nitrogen overload due to the catabolic effect of corticosteroids; however, the pathophysiological process is unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To elucidate the mechanism of hyperammonemia induced by corticosteroid administration in OTCD patients, we analyzed a mouse model by administering corticosteroids to OTC<jats:sup>spf\u2212ash<\/jats:sup> mice deficient in the OTC gene. Dexamethasone (DEX; 20\u00a0mg\/kg) was administered to the OTC<jats:sup>spf\u2212ash<\/jats:sup> and wild-type (WT) mice at 0 and 24\u00a0h, and the serum ammonia concentrations, the levels of the hepatic metabolites, and the gene expressions related with ammonia metabolism in the livers and muscles were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The ammonia levels in Otc<jats:sup>spf\u2212ash<\/jats:sup> mice that were administered DEX tended to increase at 24\u00a0h and increased significantly at 48\u00a0h. The metabolomic analysis showed that the levels of citrulline, arginine, and ornithine did not differ significantly between Otc<jats:sup>spf\u2212ash<\/jats:sup> mice that were administered DEX and normal saline; however, the level of aspartate was increased drastically in Otc<jats:sup>spf\u2212ash<\/jats:sup> mice owing to DEX administration (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). Among the enzymes associated with the urea cycle, mRNA expressions of carbamoyl-phosphate synthase 1, ornithine transcarbamylase, arginosuccinate synthase 1, and arginosuccinate lyase in the livers were significantly downregulated by DEX administration in both the Otc<jats:sup>spf\u2212ash<\/jats:sup> and WT mice (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). Among the enzymes associated with catabolism, mRNA expression of Muscle RING-finger protein-1 in the muscles was significantly upregulated in the muscles of WT mice by DEX administration (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We elucidated that corticosteroid administration induced hyperammonemia in Otc<jats:sup>spf\u2212ash<\/jats:sup> mice by not only muscle catabolism but also suppressing urea-cycle-related gene expressions. Since the urea cycle intermediate amino acids, such as arginine, might not be effective because of the suppressed expression of urea-cycle-related genes by corticosteroid administration, we should consider an early intervention by renal replacement therapy in cases of UCD patients induced by corticosteroids to avoid brain injuries or fatal outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-022-02213-0","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T13:04:13Z","timestamp":1648472653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency"],"prefix":"10.1186","volume":"22","author":[{"given":"Koji","family":"Imoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatake","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Goya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Aoyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Kohjima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"2213_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1172-7-32","volume":"7","author":"J H\u00e4berle","year":"2012","unstructured":"H\u00e4berle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Crespo PS, Santer R, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis. 2012;7:32.","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 1","key":"2213_CR2","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.ymgme.2003.10.016","volume":"81","author":"B Wilcken","year":"2004","unstructured":"Wilcken B. Problems in the management of urea cycle disorders. Mol Genet Metab. 2004;81(Suppl 1):S86-91.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"2213_CR3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10545-011-9427-0","volume":"35","author":"J Kido","year":"2012","unstructured":"Kido J, Nakamura K, Mitsubuchi H, Ohura T, Takayanagi M, Matsuo M, Yoshino M, Shigematsu Y, Yorifuji T, Kasahara M, et al. Long-term outcome and intervention of urea cycle disorders in Japan. J Inherit Metab Dis. 2012;35(5):777\u201385.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"2213_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0022-3476(99)70448-8","volume":"134","author":"NE Maestri","year":"1999","unstructured":"Maestri NE, Clissold D, Brusilow SW. Neonatal onset ornithine transcarbamylase deficiency: a retrospective analysis. J Pediatr. 1999;134(3):268\u201372.","journal-title":"J Pediatr"},{"issue":"12","key":"2213_CR5","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1001\/archneur.64.12.1777","volume":"64","author":"J Lien","year":"2007","unstructured":"Lien J, Nyhan WL, Barshop BA. Fatal initial adult-onset presentation of urea cycle defect. Arch Neurol. 2007;64(12):1777\u20139.","journal-title":"Arch Neurol"},{"issue":"1","key":"2213_CR6","first-page":"36","volume":"74","author":"GP Bijvoet","year":"2016","unstructured":"Bijvoet GP, van der Sijs-Bos CJ, Wielders JP, Groot OA. Fatal hyperammonaemia due to late-onset ornithine transcarbamylase deficiency. Neth J Med. 2016;74(1):36\u20139.","journal-title":"Neth J Med"},{"key":"2213_CR7","doi-asserted-by":"crossref","unstructured":"Gascon-Bayarri J, Campdelacreu J, Estela J, Re\u00f1\u00e9 R: Severe hyperammonemia in late-onset ornithine transcarbamylase deficiency triggered by steroid administration. Case Rep Neurol Med 2015, 2015:453752.","DOI":"10.1155\/2015\/453752"},{"issue":"11","key":"2213_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.5694\/mja15.00510","volume":"203","author":"JR Anstey","year":"2015","unstructured":"Anstey JR, Haydon TP, Ghanpur RB, de Jong G. Initial presentation of a urea cycle disorder in adulthood: an under-recognised cause of severe neurological dysfunction. Med J Aust. 2015;203(11):445\u20137.","journal-title":"Med J Aust"},{"issue":"6","key":"2213_CR9","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jimd.12100","volume":"42","author":"J H\u00e4berle","year":"2019","unstructured":"H\u00e4berle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M, Mandel H, Martinelli D, Pintos-Morell G, Santer R, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis. 2019;42(6):1192\u2013230.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2213_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0003-9861(87)90455-3","volume":"256","author":"SM Morris","year":"1987","unstructured":"Morris SM, Moncman CL, Rand KD, Dizikes GJ, Cederbaum SD, O\u2019Brien WE. Regulation of mRNA levels for five urea cycle enzymes in rat liver by diet, cyclic AMP, and glucocorticoids. Arch Biochem Biophys. 1987;256(1):343\u201353.","journal-title":"Arch Biochem Biophys"},{"key":"2213_CR11","doi-asserted-by":"crossref","unstructured":"Nebes VL, Morris SM. Regulation of messenger ribonucleic acid levels for five urea cycle enzymes in cultured rat hepatocytes. Requirements for cyclic adenosine monophosphate, glucocorticoids, and ongoing protein synthesis. Mol Endocrinol 1988, 2(5):444\u201351.","DOI":"10.1210\/mend-2-5-444"},{"issue":"2","key":"2213_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1006\/abbi.1993.1139","volume":"301","author":"C Ulbright","year":"1993","unstructured":"Ulbright C, Snodgrass PJ. Coordinate induction of the urea cycle enzymes by glucagon and dexamethasone is accomplished by three different mechanisms. Arch Biochem Biophys. 1993;301(2):237\u201343.","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"2213_CR13","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/jimd.12068","volume":"42","author":"G Allegri","year":"2019","unstructured":"Allegri G, Deplazes S, Rimann N, Causton B, Scherer T, Leff JW, Diez-Fernandez C, Klimovskaia A, Fingerhut R, Krijt J, et al. Comprehensive characterization of ureagenesis in the spf. J Inherit Metab Dis. 2019;42(6):1064\u201376.","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"2213_CR14","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/humu.20339","volume":"27","author":"S Yamaguchi","year":"2006","unstructured":"Yamaguchi S, Brailey LL, Morizono H, Bale AE, Tuchman M. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene. Hum Mutat. 2006;27(7):626\u201332.","journal-title":"Hum Mutat"},{"issue":"Suppl 3","key":"2213_CR15","doi-asserted-by":"publisher","first-page":"S196","DOI":"10.1007\/PL00014402","volume":"159","author":"M Tuchman","year":"2000","unstructured":"Tuchman M, McCullough BA, Yudkoff M. The molecular basis of ornithine transcarbamylase deficiency. Eur J Pediatr. 2000;159(Suppl 3):S196-198.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2213_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jhep.2009.11.014","volume":"52","author":"Z Ben-Ari","year":"2010","unstructured":"Ben-Ari Z, Dalal A, Morry A, Pitlik S, Zinger P, Cohen J, Fattal I, Galili-Mosberg R, Tessler D, Baruch RG, et al. Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins\u2019 diet. J Hepatol. 2010;52(2):292\u20135.","journal-title":"J Hepatol"},{"issue":"3","key":"2213_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12072-008-9078-x","volume":"2","author":"OD Klein","year":"2008","unstructured":"Klein OD, Kostiner DR, Weisiger K, Moffatt E, Lindeman N, Goodman S, Tuchman M, Packman S. Acute fatal presentation of ornithine transcarbamylase deficiency in a previously healthy male. Hepatol Int. 2008;2(3):390\u20134.","journal-title":"Hepatol Int"},{"issue":"1\u20133","key":"2213_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsbmb.2009.05.014","volume":"117","author":"AJ Dirks-Naylor","year":"2009","unstructured":"Dirks-Naylor AJ, Griffiths CL. Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy. J Steroid Biochem Mol Biol. 2009;117(1\u20133):1\u20137.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2213_CR19","doi-asserted-by":"publisher","first-page":"913","DOI":"10.4103\/2230-8210.117215","volume":"17","author":"A Gupta","year":"2013","unstructured":"Gupta A, Gupta Y. Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab. 2013;17(5):913\u20136.","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"2213_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1021\/acs.molpharmaceut.5b00516","volume":"13","author":"J Liu","year":"2016","unstructured":"Liu J, Peng Y, Wang X, Fan Y, Qin C, Shi L, Tang Y, Cao K, Li H, Long J. Mitochondrial dysfunction launches dexamethasone-induced skeletal muscle atrophy via AMPK\/FOXO3 signaling. Mol Pharm. 2016;13(1):73\u201384.","journal-title":"Mol Pharm"},{"issue":"5","key":"2213_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1046\/j.1365-2362.2002.00993.x","volume":"32","author":"E L\u00f6fberg","year":"2002","unstructured":"L\u00f6fberg E, Gutierrez A, Wernerman J, Anderstam B, Mitch WE, Price SR, Bergstr\u00f6m J, Alvestrand A. Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle. Eur J Clin Invest. 2002;32(5):345\u201353.","journal-title":"Eur J Clin Invest"},{"key":"2213_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13023-014-0105-9","volume":"9","author":"C Cavicchi","year":"2014","unstructured":"Cavicchi C, Donati M, Parini R, Rigoldi M, Bernardi M, Orfei F, Gentiloni Silveri N, Colasante A, Funghini S, Catarzi S, et al. Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment. Orphanet J Rare Dis. 2014;9:105.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2213_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/01.mcg.0000225628.84168.25","volume":"42","author":"M Atiq","year":"2008","unstructured":"Atiq M, Holt AF, Safdar K, Weber F, Ravinuthala R, Jonas ME, Neff GW. Adult onset urea cycle disorder in a patient with presumed hepatic encephalopathy. J Clin Gastroenterol. 2008;42(2):213\u20134.","journal-title":"J Clin Gastroenterol"},{"issue":"10","key":"2213_CR24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/jp.2011.23","volume":"31","author":"S Lipskind","year":"2011","unstructured":"Lipskind S, Loanzon S, Simi E, Ouyang DW. Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids. J Perinatol. 2011;31(10):682\u20134.","journal-title":"J Perinatol"},{"issue":"4 Suppl","key":"2213_CR25","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ccc.2005.05.002","volume":"21","author":"ML Summar","year":"2005","unstructured":"Summar ML, Barr F, Dawling S, Smith W, Lee B, Singh RH, Rhead WJ, Sniderman King L, Christman BW. Unmasked adult-onset urea cycle disorders in the critical care setting. Crit Care Clin. 2005;21(4 Suppl):S1-8.","journal-title":"Crit Care Clin"},{"issue":"4","key":"2213_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/ams2.214","volume":"3","author":"H Mitani","year":"2016","unstructured":"Mitani H, Mochizuki T, Otani N, Tanaka H, Ishimatsu S. Ornithine transcarbamylase deficiency that developed at the age of 19 years with acute brain edema. Acute Med Surg. 2016;3(4):419\u201323.","journal-title":"Acute Med Surg"},{"issue":"2","key":"2213_CR27","first-page":"205","volume":"7","author":"PJ McGuire","year":"2014","unstructured":"McGuire PJ, Tarasenko TN, Wang T, Levy E, Zerfas PM, Moran T, Lee HS, Bequette BJ, Diaz GA. Acute metabolic decompensation due to influenza in a mouse model of ornithine transcarbamylase deficiency. Dis Model Mech. 2014;7(2):205\u201313.","journal-title":"Dis Model Mech"},{"issue":"2","key":"2213_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s004390050333","volume":"99","author":"A Nishiyori","year":"1997","unstructured":"Nishiyori A, Yoshino M, Kato H, Matsuura T, Hoshide R, Matsuda I, Kuno T, Miyazaki S, Hirose S, Kuromaru R, et al. The R40H mutation in a late onset type of human ornithine transcarbamylase deficiency in male patients. Hum Genet. 1997;99(2):171\u20136.","journal-title":"Hum Genet"},{"issue":"7","key":"2213_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2169\/internalmedicine.1851-18","volume":"58","author":"Y Koya","year":"2019","unstructured":"Koya Y, Shibata M, Senju M, Honma Y, Hiura M, Ishii M, Matsumoto S, Harada M. Hyperammonemia in a woman with late-onset ornithine transcarbamylase deficiency. Intern Med. 2019;58(7):937\u201342.","journal-title":"Intern Med"},{"key":"2213_CR30","doi-asserted-by":"crossref","unstructured":"Hidaka M, Higashi E, Uwatoko T, Uwatoko K, Urashima M, Takashima H, Watanabe Y, Kitazono T, Sugimori H. Late-onset ornithine transcarbamylase deficiency: a rare cause of recurrent abnormal behavior in adults. Acute Med Surg 2020, 7(1):e565.","DOI":"10.1002\/ams2.565"},{"key":"2213_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/CEG.S160921","volume":"11","author":"DG Levitt","year":"2018","unstructured":"Levitt DG, Levitt MD. A model of blood-ammonia homeostasis based on a quantitative analysis of nitrogen metabolism in the multiple organs involved in the production, catabolism, and excretion of ammonia in humans. Clin Exp Gastroenterol. 2018;11:193\u2013215.","journal-title":"Clin Exp Gastroenterol"},{"issue":"3\u20134","key":"2213_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1357-2725(98)00121-6","volume":"31","author":"R McCauley","year":"1999","unstructured":"McCauley R, Kong SE, Heel K, Hall JC. The role of glutaminase in the small intestine. Int J Biochem Cell Biol. 1999;31(3\u20134):405\u201313.","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"2213_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/gut.14.3.171","volume":"14","author":"A Vince","year":"1973","unstructured":"Vince A, Dawson AM, Park N, O\u2019Grady F. Ammonia production by intestinal bacteria. Gut. 1973;14(3):171\u20137.","journal-title":"Gut"},{"issue":"1","key":"2213_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1006\/jsre.1994.1136","volume":"57","author":"P Sarantos","year":"1994","unstructured":"Sarantos P, Abouhamze Z, Copeland EM, Souba WW. Glucocorticoids regulate glutaminase gene expression in human intestinal epithelial cells. J Surg Res. 1994;57(1):227\u201331.","journal-title":"J Surg Res"},{"issue":"11","key":"2213_CR35","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.metabol.2012.07.007","volume":"61","author":"MM Adeva","year":"2012","unstructured":"Adeva MM, Souto G, Blanco N, Donapetry C. Ammonium metabolism in humans. Metabolism. 2012;61(11):1495\u2013511.","journal-title":"Metabolism"},{"issue":"5","key":"2213_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ki.1975.117","volume":"8","author":"MA Knepper","year":"1975","unstructured":"Knepper MA, Danielson RA, Saidel GM, Johnston KH. Effects of dietary protein restriction and glucocorticoid administration on urea excretion in rats. Kidney Int. 1975;8(5):303\u201315.","journal-title":"Kidney Int"},{"issue":"4","key":"2213_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/ped.12439","volume":"56","author":"K Nakamura","year":"2014","unstructured":"Nakamura K, Kido J, Mitsubuchi H, Endo F. Diagnosis and treatment of urea cycle disorder in Japan. Pediatr Int. 2014;56(4):506\u20139.","journal-title":"Pediatr Int"},{"issue":"1","key":"2213_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0925-4439(99)00048-4","volume":"1455","author":"MX Li","year":"1999","unstructured":"Li MX, Nakajima T, Fukushige T, Kobayashi K, Seiler N, Saheki T. Aberrations of ammonia metabolism in ornithine carbamoyltransferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator. Biochim Biophys Acta. 1999;1455(1):1\u201311.","journal-title":"Biochim Biophys Acta"},{"key":"2213_CR39","doi-asserted-by":"crossref","unstructured":"Batshaw ML, MacArthur RB, Tuchman M. Alternative pathway therapy for urea cycle disorders: twenty years later. J Pediatr 2001, 138(1 Suppl):S46\u201354; discussion S54\u201345.","DOI":"10.1067\/mpd.2001.111836"},{"issue":"2","key":"2213_CR40","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/hepr.13255","volume":"49","author":"K Fujiwara","year":"2019","unstructured":"Fujiwara K, Abe R, Yasui S, Yokosuka O, Kato N, Oda S. High recovery rate of consciousness by high-volume filtrate hemodiafiltration for fulminant hepatitis. Hepatol Res. 2019;49(2):224\u201331.","journal-title":"Hepatol Res"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02213-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02213-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02213-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T13:05:11Z","timestamp":1648472711000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02213-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2213"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02213-0","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"17 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed following the Guide for the Care and Use of Laboratory Animals (National Institutes of Health) and approved by the Animal Care Committee of Kyushu University. This study was reported in accordance with ARRIVE guidelines. Two cases presented in this study were approved by the Ethics Committee of Kyushu University Hospital (No.28-432), and all methods were performed in accordance with the relevant guidelines and regulations. Informed consent was waived because of the retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}